Organovo Holdings, Inc. (ONVO) Is At $1.01 Formed Wedge; Last Week UBS Group AG (UBS) Analysts

UBS Group AG (NYSE:UBS) Logo

Among 12 analysts covering UBS AG (NYSE:UBS), 6 have Buy rating, 0 Sell and 6 Hold. Therefore 50% are positive. UBS AG had 21 analyst reports since September 15, 2015 according to SRatingsIntel. JP Morgan upgraded UBS Group AG (NYSE:UBS) on Monday, June 26 to “Overweight” rating. The rating was upgraded by Morgan Stanley on Tuesday, December 6 to “Overweight”. The stock of UBS Group AG (NYSE:UBS) has “Neutral” rating given on Wednesday, October 28 by JP Morgan. The firm has “Buy” rating by Societe Generale given on Wednesday, January 11. The stock of UBS Group AG (NYSE:UBS) has “Sector Perform” rating given on Wednesday, February 3 by RBC Capital Markets. The stock of UBS Group AG (NYSE:UBS) earned “Outperform” rating by Keefe Bruyette & Woods on Thursday, November 10. Bank of America upgraded UBS Group AG (NYSE:UBS) on Wednesday, October 7 to “Buy” rating. The firm earned “Hold” rating on Tuesday, February 9 by Kepler Cheuvreux. The stock of UBS Group AG (NYSE:UBS) has “Hold” rating given on Friday, May 13 by Societe Generale. The stock of UBS Group AG (NYSE:UBS) earned “Underperform” rating by RBC Capital Markets on Tuesday, June 28. See UBS Group AG (NYSE:UBS) latest ratings:

10/11/2017 Broker: Bank of America Old Rating: Neutral New Rating: Buy Upgrade

Organovo Holdings, Inc. (ONVO) formed wedge down with $0.93 target or 8.00% below today’s $1.01 share price. Organovo Holdings, Inc. (ONVO) has $111.94 million valuation. The stock decreased 3.81% or $0.04 during the last trading session, reaching $1.01. About 461,274 shares traded. Organovo Holdings, Inc. (NASDAQ:ONVO) has declined 67.42% since April 15, 2017 and is downtrending. It has underperformed by 78.97% the S&P500.

Analysts await Organovo Holdings, Inc. (NASDAQ:ONVO) to report earnings on June, 6. They expect $-0.07 earnings per share, up 30.00% or $0.03 from last year’s $-0.1 per share. After $-0.07 actual earnings per share reported by Organovo Holdings, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Investors sentiment decreased to 0.67 in 2017 Q4. Its down 0.86, from 1.53 in 2017Q3. It dropped, as 16 investors sold Organovo Holdings, Inc. shares while 38 reduced holdings. 18 funds opened positions while 18 raised stakes. 20.74 million shares or 13.74% less from 24.05 million shares in 2017Q3 were reported. Blackrock accumulated 6.12M shares or 0% of the stock. Moreover, Raymond James Fincl Svcs Advisors has 0% invested in Organovo Holdings, Inc. (NASDAQ:ONVO) for 41,082 shares. Meeder Asset Mgmt has invested 0% in Organovo Holdings, Inc. (NASDAQ:ONVO). 3,271 are owned by Tower Research Ltd Liability (Trc). Moreover, Principal Fincl Grp Incorporated Inc has 0% invested in Organovo Holdings, Inc. (NASDAQ:ONVO) for 15,233 shares. Citadel Advsrs Ltd Liability Co reported 0% stake. Lehman Financial Resource has invested 0.11% of its portfolio in Organovo Holdings, Inc. (NASDAQ:ONVO). Lpl Llc reported 0% in Organovo Holdings, Inc. (NASDAQ:ONVO). Deltec Asset Mngmt Ltd invested in 0% or 10,000 shares. 89,789 are held by Rhumbline Advisers. Deutsche Bancshares Ag has 253,790 shares for 0% of their portfolio. 32,500 are held by Cue Gru. Valley National Advisers holds 2,650 shares or 0% of its portfolio. Moreover, Pnc Fincl Grp has 0% invested in Organovo Holdings, Inc. (NASDAQ:ONVO) for 8,600 shares. California-based California State Teachers Retirement Systems has invested 0% in Organovo Holdings, Inc. (NASDAQ:ONVO).

Organovo Holdings, Inc. (NASDAQ:ONVO) Institutional Positions Chart